Dr. Hooman Poor, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $29,323 | 13 | 87.5% |
| Travel and Lodging | $3,238 | 12 | 9.7% |
| Food and Beverage | $726.29 | 21 | 2.2% |
| Education | $124.60 | 6 | 0.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $100.00 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| United Therapeutics Corporation | $12,756 | 29 | $0 (2023) |
| Vertex Pharmaceuticals Incorporated | $9,405 | 2 | $0 (2022) |
| Merck Sharp & Dohme LLC | $7,417 | 8 | $0 (2024) |
| VIVUS LLC | $2,570 | 1 | $0 (2021) |
| Baxter Healthcare | $550.00 | 2 | $0 (2021) |
| Bayer Healthcare Pharmaceuticals Inc. | $392.80 | 6 | $0 (2024) |
| GlaxoSmithKline, LLC. | $230.00 | 1 | $0 (2018) |
| Actelion Pharmaceuticals US, Inc. | $159.60 | 2 | $0 (2023) |
| Gilead Sciences, Inc. | $31.91 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,007 | 8 | Merck Sharp & Dohme LLC ($6,807) |
| 2023 | $5,968 | 14 | United Therapeutics Corporation ($5,322) |
| 2022 | $14,508 | 13 | Vertex Pharmaceuticals Incorporated ($9,000) |
| 2021 | $5,384 | 10 | VIVUS LLC ($2,570) |
| 2020 | $225.00 | 2 | Bayer HealthCare Pharmaceuticals Inc. ($125.00) |
| 2019 | $31.91 | 2 | Gilead Sciences, Inc. ($31.91) |
| 2018 | $371.69 | 3 | GlaxoSmithKline, LLC. ($230.00) |
| 2017 | $17.52 | 1 | Bayer HealthCare Pharmaceuticals Inc. ($17.52) |
All Payment Transactions
53 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/28/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $5,490.00 | General |
| 10/28/2024 | Merck Sharp & Dohme LLC | — | Travel and Lodging | Cash or cash equivalent | $195.46 | General |
| 10/28/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $16.82 | General |
| 10/17/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Travel and Lodging | In-kind items and services | $694.27 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/16/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Travel and Lodging | In-kind items and services | $388.43 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/10/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Education | In-kind items and services | $10.85 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug) | Consulting Fee | Cash or cash equivalent | $200.00 | General |
| Category: Cardio-pulmonary | ||||||
| 07/12/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Education | In-kind items and services | $10.85 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/11/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $610.00 | General |
| 08/22/2023 | United Therapeutics Corporation | TYVASO (Drug) | Consulting Fee | Cash or cash equivalent | $4,200.00 | General |
| Category: PAH | ||||||
| 08/04/2023 | United Therapeutics Corporation | TYVASO (Drug) | Travel and Lodging | In-kind items and services | $103.17 | General |
| Category: PAH | ||||||
| 08/04/2023 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $60.95 | General |
| Category: PAH | ||||||
| 08/04/2023 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $50.35 | General |
| Category: PAH | ||||||
| 08/04/2023 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $27.83 | General |
| Category: PAH | ||||||
| 08/04/2023 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: PAH | ||||||
| 08/04/2023 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: PAH | ||||||
| 08/04/2023 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $6.04 | General |
| Category: PAH | ||||||
| 08/03/2023 | United Therapeutics Corporation | TYVASO (Drug) | Travel and Lodging | In-kind items and services | $261.06 | General |
| Category: PAH | ||||||
| 08/03/2023 | United Therapeutics Corporation | TYVASO (Drug) | Travel and Lodging | In-kind items and services | $50.15 | General |
| Category: PAH | ||||||
| 08/03/2023 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $31.00 | General |
| Category: PAH | ||||||
| 07/31/2023 | United Therapeutics Corporation | TYVASO (Drug) | Travel and Lodging | In-kind items and services | $483.90 | General |
| Category: PAH | ||||||
| 02/14/2023 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $35.60 | General |
| Category: Cardiology | ||||||
| 11/21/2022 | United Therapeutics Corporation | — | Consulting Fee | Cash or cash equivalent | $4,200.00 | General |
| 10/28/2022 | United Therapeutics Corporation | — | Travel and Lodging | In-kind items and services | $115.31 | General |
| 10/28/2022 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $68.88 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 519 | 995 | $776,210 | $145,187 |
| 2022 | 10 | 455 | 862 | $653,550 | $134,471 |
| 2021 | 9 | 343 | 737 | $581,865 | $107,630 |
| 2020 | 8 | 327 | 719 | $645,674 | $113,056 |
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 128 | 316 | $395,000 | $65,947 | 16.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 76 | 145 | $63,800 | $18,039 | 28.3% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 62 | 148 | $92,500 | $15,975 | 17.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 63 | 112 | $54,600 | $13,756 | 25.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 58 | 64 | $51,200 | $10,878 | 21.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 28 | 88 | $36,080 | $10,498 | 29.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 14 | 14 | $9,380 | $2,184 | 23.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 14 | 14 | $9,540 | $2,159 | 22.6% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2023 | 13 | 13 | $7,930 | $1,587 | 20.0% |
| 31500 | Emergent insertion of breathing tube into windpipe using an endoscope | Facility | 2023 | 12 | 12 | $5,400 | $1,583 | 29.3% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2023 | 17 | 20 | $40,000 | $1,495 | 3.7% |
| 36620 | Insertion of artery tube for blood sampling or infusion through skin | Facility | 2023 | 12 | 16 | $8,800 | $649.76 | 7.4% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2023 | 22 | 33 | $1,980 | $436.59 | 22.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 115 | 285 | $356,250 | $63,272 | 17.8% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 63 | 134 | $83,750 | $15,008 | 17.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 63 | 101 | $44,440 | $13,596 | 30.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 51 | 58 | $46,400 | $11,528 | 24.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 23 | 112 | $45,920 | $11,300 | 24.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 44 | 63 | $31,920 | $8,529 | 26.7% |
| 31500 | Emergent insertion of breathing tube into windpipe using an endoscope | Facility | 2022 | 14 | 15 | $6,750 | $2,048 | 30.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 12 | 12 | $8,360 | $2,002 | 23.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 11 | 11 | $7,370 | $1,943 | 26.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 20 | 23 | $8,210 | $1,818 | 22.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 15 | 21 | $6,510 | $1,817 | 27.9% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2022 | 11 | 11 | $6,710 | $1,408 | 21.0% |
About Dr. Hooman Poor, MD
Dr. Hooman Poor, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2008. The National Provider Identifier (NPI) number assigned to this provider is 1982863502.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hooman Poor, MD has received a total of $33,512 in payments from pharmaceutical and medical device companies, with $7,007 received in 2024. These payments were reported across 53 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($29,323).
As a Medicare-enrolled provider, Poor has provided services to 1,644 Medicare beneficiaries, totaling 3,313 services with total Medicare billing of $500,344. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Pulmonary Disease
- Location New York, NY
- Active Since 06/09/2008
- Last Updated 07/17/2013
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1982863502
Products in Payments
- TYVASO (Drug) $7,078
- WINREVAIR (Biological) $1,104
- Fluid Systems - Drug Delivery Systems (Device) $550.00
- Adempas (Drug) $378.49
- ANORO (Drug) $230.00
- ORENITRAM (Drug) $70.31
- UPTRAVI (Drug) $35.60
- Letairis (Drug) $31.91
- Verquvo (Drug) $14.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in New York
Dr. Saakshi Khattri, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $1.7M
Cheguevara Afaneh, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $1.5M
John Allan, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $550,557
Jose Scher, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $496,980
Dr. Anthony Rossi, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $442,377
Anuradha Lala-Trindade
Student in an Organized Health Care Education/Training Program — Payments: $284,341